News

Our Healthcare News

Cognate BioServices closes Series B and completes acquisition of Cobra Biologics

MEMPHIS, Tennessee—Cognate BioServices, a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated gene therapy products today announced that it has completed…  

Jan 21 2020

Sonendo® Announces Growth Investment from EW Healthcare Partners

 
Leading Dental Technology Company Raises $85 Million to Accelerate Growth

LAGUNA HILLS, California—Sonendo, Inc., a leading dental technology company, announced today that…  

Jan 06 2020

TELA Bio Announces Closing of Initial Public Offering of Common Stock

MALVERN, Pennsylvania—TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement…  

Dec 13 2019

TELA Bio Awarded Contract with HealthTrust Purchasing Group

MALVERN, Pennsylvania—TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement…  

Dec 06 2019

Knight Therapeutics Announces Closing of Previously Announced Acquisition of Grupo Biotoscana

MONTREAL, Canada—Knight Therapeutics Inc. (TSX: GUD) (“Knight”) today announced that it has completed the acquisition of a 51.2% interest in Biotoscana Investments S.A. (B3: GBIO33)…  

Nov 29 2019

Sonendo Named to Inc. 5000 List of Fastest-Growing Private Companies

LAGUNA HILLS, California—Inc. magazine today revealed that Sonendo®, developer of the GentleWave® System, is No. 19 on its annual Inc. 5000 list of the nation’s…  

Oct 05 2019

Cognate BioServices Secures Growth Capital Investment from EW Healthcare to Continue to Expand Commercial Manufacturing Capacity and Services for the Cellular Therapies Industry

BALTIMORE & MEMPHIS, Tennessee –(BUSINESS WIRE)–Cognate BioServices, a leading contract development and manufacturing organization (“CDMO”) in the global cellular therapies industry, announced today it has…  

Aug 26 2019

EW Healthcare Partners Raises Over $745 Million Fund 2

Team of Experienced Healthcare Investors and Former Healthcare Executives Will Invest in Select Healthcare Companies to Seek to Accelerate Their Revenue Growth

Partner and Principals…  

Aug 22 2019

LightStrike Robot Proven Effective at Destroying Deadly Superbug Candida auris in New Published Study

SAN ANTONIO—(BUSINESS WIRE)—Candida auris (C.auris) is an emerging, often multi-drug resistant, fungus that causes serious and often deadly infections in healthcare settings. The Centers for…  

Jul 08 2019



View Legacy Fund news >